-
Symbol
-
ANRO on NYSE
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Shares Owned
-
788,995 shares
-
Security Ownership %
-
2.4%
K2 HealthVentures Equity Trust LLC ownership in Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share (ANRO)
17 Feb 2026 - K2 HealthVentures Equity Trust LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 788,995 shares of Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share (ANRO).
This represents 2.4% ownership of the company.
In their previous filing dated 15 May 2025, K2 HealthVentures Equity Trust LLC had reported owning 1,617,855 shares, indicating a decrease of +51%.
.